Quotient Sciences and CPI join forces to accelerate RNA drug development
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The complex four-hour surgery was performed by a multidisciplinary team of doctors
The facility will be positioned as a Centre of Excellence for tertiary care services
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
Subscribe To Our Newsletter & Stay Updated